Abbott Laboratories
ABT
$133.70
Share price
-0.55%
Change (1 day)
30.92%
Change (1 year)
Categories
Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.
Abbott Laboratories (ABT) - Total assets
Total assets on the balance sheet as of March 2025 : $81.44 Billion USD
According to Abbott Laboratories's latest financial reports the company's total assets are $81.44 Billion USD. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Abbott Laboratories - Total assets on balance sheet (from 2001 to 2025)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2024-12-31 | $81.41 B | 11.2% |
| 2023-12-31 | $73.21 B | -1.64% |
| 2022-12-31 | $74.43 B | -1.01% |
| 2021-12-31 | $75.19 B | 3.65% |
| 2020-12-31 | $72.54 B | 6.87% |
| 2019-12-31 | $67.88 B | 1.06% |
| 2018-12-31 | $67.17 B | -11.9% |
| 2017-12-31 | $76.25 B | 44.78% |
| 2016-12-31 | $52.66 B | 27.68% |
| 2015-12-31 | $41.24 B | 0.1% |
| 2014-12-31 | $41.20 B | -4.06% |
| 2013-12-31 | $42.95 B | -36.12% |
| 2012-12-31 | $67.23 B | 11.54% |
| 2011-12-31 | $60.27 B | -0.49% |
| 2010-12-31 | $60.57 B | 15.56% |
| 2009-12-31 | $52.41 B | 23.57% |
| 2008-12-31 | $42.41 B | 6.81% |
| 2007-12-31 | $39.71 B | 9.77% |
| 2006-12-31 | $36.17 B | 24.15% |
| 2005-12-31 | $29.14 B | 1.3% |
| 2004-12-31 | $28.76 B | 10.48% |
| 2003-12-31 | $26.03 B | 7.34% |
| 2002-12-31 | $24.25 B | 4.13% |
| 2001-12-31 | $23.29 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $193.67 B | 137.78% | 🇺🇸 USA |
 Pfizer PFE | $208.02 B | 155.41% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | $99.04 B | 21.60% | 🇺🇸 USA |
 Hologic HOLX | $8.54 B | -89.51% | 🇺🇸 USA |
 Medtronic MDT | $91.68 B | 12.56% | 🇮🇪 Ireland |
 Bristol-Myers Squibb BMY | $92.42 B | 13.48% | 🇺🇸 USA |
 Boston Scientific BSX | $40.14 B | -50.72% | 🇺🇸 USA |
 AstraZeneca AZN | $106.25 B | 30.46% | 🇬🇧 UK |
 Novartis NVS | $99.94 B | 22.71% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | $78.43 B | -3.70% | 🇬🇧 UK |